Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
10/2001
10/04/2001DE10015520A1 Verfahren zur 1,3-dipolaren Cycloaddition organischer Verbindungen Method for 1,3-dipolar cycloaddition of organic compounds
10/04/2001DE10015518A1 Verfahren zur Oximierung organischer Carbonylverbindungen und/oder CH-acider Verbindungen Method for oximating organic carbonyl compounds and / or CH-acidic compounds
10/04/2001CA2404445A1 Tricyclic protein kinase inhibitors
10/03/2001CN1072224C Condensed 'beta'-carbolines
10/02/2001US6297237 Process for the preparation of aminocarbonyl derivatives of geneseroline having selective brain anticholinesterase activity
09/2001
09/27/2001WO2001070731A1 Decahydro-isoquinolines
09/27/2001WO2001070229A1 Thrombin inhibitors
09/27/2001US20010025047 Nitrogen containing bicyclic heteroaromatic compound containing sulfonamide and hydroxyamide groups, useful in treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, bone disease and HIV infections
09/27/2001US20010024798 Biomimetic combinatorial synthesis
09/27/2001CA2403558A1 Thrombin inhibitors
09/26/2001EP1135470A2 Recombinant methods and materials for producing epothilone and epothilone derivatives
09/25/2001US6294671 Isoxazolo[4, 5-D]pyrimidines as CRF antagonists
09/25/2001US6294530 Heterocyclic compounds for nervous system disorders
09/20/2001WO2001068641A1 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viral diseases
09/20/2001WO2001068568A2 Il-8 receptor antagonists
09/20/2001DE10013126A1 New 6-aminoalkyl-dihydropyrimidine-5-carboxylate ester derivatives, useful as antiviral agents having strong activity against hepatitis B virus and low cytotoxicity
09/20/2001CA2402891A1 Il-8 receptor antagonists
09/20/2001CA2402549A1 Substituted beta-carbolines
09/19/2001EP1134219A1 Cycloalkyl-substituted aminomethylpyrrolidine derivatives
09/19/2001EP1133293A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
09/18/2001US6291505 Pyrazole estrogen receptor agonist and antagonist
09/18/2001US6291474 Bicyclic amine derivatives
09/18/2001US6291469 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
09/13/2001WO2001066546A1 Spiro compounds, process for preparing the same and use thereof as drugs
09/13/2001WO2001066544A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
09/13/2001WO2001066520A1 Indole derivatives, process for preparation of the same and use thereof
09/13/2001WO2001028992A3 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
09/13/2001CA2402179A1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
09/13/2001CA2402174A1 Indole derivatives, process for preparation of the same and use thereof
09/12/2001EP1132432A2 Preparation process of pigments
09/12/2001EP1131295A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
09/12/2001EP1131073A1 Use of staurosporine derivatives for treating ocular neovascular diseases
09/12/2001EP0629203B1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents
09/12/2001CN1070855C 4-thiocarbamoyl-1-(3-pyrazoly)-pyrazoles and their use as herbicides
09/11/2001US6288234 Fluorinated heterocyclic amido amine compounds as drugs
09/11/2001US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation
09/11/2001US6288083 Chemokine receptor antagonists and methods of use therefor
09/11/2001US6288073 Acronycine derivatives, preparation method and pharmaceutical compositions
09/07/2001WO2001064686A1 3-aza-6,8-dioxabicyclo[3.2.1]octanes and analogues and combinatorial libraries
09/07/2001WO2001064655A1 2, 4-di(hetero-)arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
09/07/2001WO2001028990A3 Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof
09/07/2001WO2001018008A3 Decahydronaphthalene derivatives for molecular signal transduction
09/07/2001WO2001000197A3 Methods of treating fungal infections with inhibitors of nad synthetase enzyme
09/07/2001CA2398685A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/05/2001EP1130022A1 3-Aza-6,8-dioxabicyclo[3.2.1]octanes and analogues and combinatorial libraries containing them
09/05/2001EP1130017A2 Azole derivatives and their use as superoxide radical inhibitors
09/05/2001EP1129097A1 Novel type condensed pyridazinone compounds
09/05/2001EP0699185B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS
09/05/2001CN1311773A Neuropeptide Y5 receptor antagonists
09/05/2001CN1070493C Heterocyclic condensed furanpyranoid ring compound and herbicides
09/05/2001CN1070481C Use of dioxomorpholines to combact endopharasites, movel dioxomopholines and process for their prodn.
09/04/2001US6284889 Chromophoric compounds and process for their preparation
09/04/2001US6284784 2-hydroxymethyl derivatives
09/04/2001US6284772 Indolo[2,1-B] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith
09/04/2001US6284764 Antiproliferative agent
08/2001
08/30/2001WO2001062736A1 Aryl fused azapolycyclic compounds
08/30/2001WO2001011968A3 Heterocyclic spiro compounds as pesticides
08/29/2001EP1127140A2 Fk506-based regulation of biological events
08/29/2001EP1126855A1 Methods for preventing/treating damage to sensory hair cells and cochlear neurons
08/29/2001EP1126845A2 New use of immunosuppressants for mmp-mediated diseases
08/29/2001CN1310624A Extraction method, pharmaceutical composition and a cosmetic composition
08/29/2001CN1070191C Novel quinolone-or naphthyridonecarboxylic acid derivative or salt thereof
08/28/2001US6281352 Antiinflammatory agents
08/23/2001WO2001060803A1 Fused imidazolium derivatives
08/23/2001US20010016598 Erythromycins and process for their preparation
08/22/2001EP1125986A2 New Triphendioxazine pigments
08/22/2001EP1125938A1 Protein kinase inhibitors for treatment of neurological disorders
08/22/2001EP1124831A2 Sodium salt of 3-(4-cinnamyl-1-piperazinyl)imino-methyl rifamycin sv and process of preparation
08/22/2001EP1124528A1 Multivalent macrolide antibiotics
08/22/2001CN1069899C Process for manufacture of azepines and intermidiate thereof
08/21/2001US6277851 Bicyclic amino-pyrazinone compounds
08/21/2001CA2054203C Macrolides for the treatment of reversible obstructive air-ways diseases
08/16/2001WO2001058905A1 Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds
08/16/2001WO2001058904A1 Apoptosis-inducing compounds
08/16/2001WO2001058876A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
08/16/2001WO2001058869A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
08/16/2001WO2001009190A3 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
08/16/2001WO2001009119A3 Chemokine receptor antagonists
08/16/2001EP1123297A1 New compounds, their preparation and use
08/16/2001EP0828715B1 N-oxides as antibacterial agents
08/16/2001EP0765329B1 Rapamycin amidino carbamates and pharmaceutical compositions containing them
08/16/2001CA2400102A1 Apoptosis-inducing compounds
08/16/2001CA2399791A1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
08/09/2001WO2001057044A1 Pyridoxazine derivatives
08/09/2001WO2001057042A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
08/09/2001WO2001057002A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
08/09/2001CA2398674A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
08/08/2001EP1122252A1 Nitrogenous fused heterocycle compounds, process for the preparation thereof and agents containing the same
08/08/2001EP1009749B1 Preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxyamide
08/08/2001CN1307581A Method for producing anellated triazoles and new anellated trizoles and their use
08/08/2001CN1307475A Medicinal compositions
08/08/2001CN1069317C Novel indane-2-mercaptoacetamide disulfide derivs, useful as inhibitors of enkephaliinase
08/08/2001CN1069195C Prep. of suspendible composition
08/08/2001CN1069193C Prep. of ointments containing tricyclic compound
08/07/2001US6271255 Useful as antibacterial and antiprotozoal agents in infections in mammals, fish, and birds
08/07/2001US6271251 Cardiovascular disorders
08/07/2001US6271242 Adminstering (8r*,9s*,11s*)-(-)-9-hydroxy-9-methoxycarbonyl-8-methyl-2,3,9,10-tetrahydro -8,11-epoxy-(1h, 8h, 11h) 2, 7b, 11a-triazadibenzo(a, g)cycloocta(c,d,e)triinden-1-one as treatment of cancer induced by trk oncogene protein
08/07/2001US6271225 Fused thiophene compounds and medicinal use thereof
08/02/2001WO2001055143A1 Benzoxazole derivatives and their use as pesticides
08/02/2001WO2001055119A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto